UBS initiates Zions Bancorp stock with buy rating on NII outlook

UBS initiated Zions Bancorp with a Buy rating and $78 price target, implying roughly 13% upside from its $68.75 trading price. UBS forecasts 7.7% net interest income growth over the next 12 months versus 5.8% consensus and projects FY2027 EPS of $7.06, about 3% above consensus, supported by asset sensitivity and improving deposits. Other analysts have also raised targets to $73-$84, while management targets 100-150bps of pre-provision operating leverage by 2026.

Analysis

ZION’s upside is primarily a duration-and-deposit-beta thesis, not a durable idiosyncratic rerating. If short-end rates remain elevated while deposit repricing moderates, incremental NII can fall disproportionately to pre-provision earnings given the bank’s relatively modest loan-to-deposit ratio. The market is likely to focus less on a 2028 terminal multiple than on whether quarterly deposit costs, noninterest-bearing deposit mix, and commercial-loan yields validate the implied NII acceleration over the next two earnings reports.

The key second-order risk is that the same higher-for-longer curve supporting asset yields can eventually surface in C&I and commercial real-estate credit, where regional-bank multiples contract quickly once provisioning normalizes. ZION’s apparent earnings discount therefore may be rational if investors expect credit costs to rise from unusually benign levels or if operating-expense discipline fails to convert revenue growth into positive jaws. A softer labor market or faster-than-expected Fed easing would also compress the asset-sensitivity benefit within 1-3 months.

Consensus appears too willing to extrapolate a favorable rate setup into 2027. The more investable catalyst is a near-term upward revision cycle if management demonstrates deposit growth without materially higher funding costs; absent that evidence, the stock has limited reason to close the valuation gap versus stronger scale regional franchises. Watch quarterly NII guidance, cumulative deposit beta, criticized-loan migration, and CET1 trends rather than headline EPS beats driven by low provisions.

Key Decisions for Investors

• Initiate a tactical long ZION only on confirmation of improved deposit flows and stable-to-lower deposit costs at the next earnings release; target $78-$84 over 3-6 months versus a stop near $63. The setup offers roughly 2:1 upside/downside, but is contingent on NII guidance moving above consensus.
• Express the rate-sensitive regional-bank view as long ZION / short KRE in equal dollar amounts for 3-6 months, isolating bank-specific funding and operating-leverage execution from a broad regional-bank risk-off move. Exit if ZION’s NII outlook is not raised or if criticized assets accelerate sequentially.
• Avoid treating the stated long-term earnings framework as a standalone valuation catalyst. Set alerts for a meaningful decline in front-end Treasury yields or a quarterly provision build above expectations; either would undermine the earnings-revision case and favor reducing exposure.
• For existing longs, use $80-$85 as a reassessment zone rather than a buy-and-hold target: at that range, upside requires a sustained premium multiple despite unresolved credit normalization risk.